Physiomics Share News (PYC)
PYC Share
PYC Share
PYC Share
PYC Share
PYC
PYC Share
PYC Level 2
PYC Live
PYC Broker
PYC Directors
PYC Financial
PYC
PYC Short
PYC
Last checked at -
Thu, 28th Nov 2013 15:10
LONDON (Alliance News) - Shares in Physiomics PLC jumped 19% Thursday after it launched its drug combinations and regimens database DrugCard.
DrugCard collects publicly available pre-clinical and clinical drug regimen data into a searchable database.
Shares in the biotechnology company were trading up 19% at 0.190 pence Thursday afternoon.
By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews
Copyright © 2013 Alliance News Limited. All Rights Reserved.
(Alliance News) - ValiRx PLC on Thursday reported an increased half-year loss amid higher costs, as it continued to focus on building its science-focused portfolio.
Read more
(Sharecast News) - Mathematical modelling company Physiomics, which specialises in the development of oncology drugs and personalised medicine, confirmed a renewed contract with Numab Therapeutics on Tuesday.
Read morePhysiomics PLC - London-based mathematical modelling company that supports oncology drug development - Says it has been awarded a further contract by its existing client, Numab Therapeutics. Numab Therapeutics is a Switzerland-based biotechnology firm. The project involves pharmacokinetic-pharmacodynamic modelling in support of one of Numab's clinical programs and follows on from earlier work conducted by Physiomics on the same asset. The project will span two years of the clinical program.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued Thursday and not separately reported by Alliance News:
Read more(Alliance News) - Physiomics PLC on Tuesday said it had completed a fundraise, conditional on admission, of GBP335,000 through a placing with Hybridan LLP, and announced a retail offer from Winterflood retail access platform to raise a maximum of GPB150,000.
Read more(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.
Read more(Alliance News) - Physiomics PLC on Wednesday said it will collaborate with the University of Sheffield on research into an insect model of cancer treatment.
Read more(Alliance News) - Physiomics PLC shares fell on Tuesday, after it lowered its full-year outlook by more than 10%.
Read more(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Read more(Sharecast News) - Physiomics announced on Wednesday that it has signed a collaborative services agreement with Inaphaea BioLabs - a wholly-owned subsidiary of ValiRx.
Read more(Sharecast News) - Physiomics announced its participation in the American Association for Cancer Research (AACR) annual meeting on Friday, being held in Orlando on 14-19 April.
Read more(Alliance News) - Physiomics PLC on Tuesday announced that its revenue was hampered by pressure resulting from low biotechnology funding.
Read more(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Read more
Last checked at